PGD

Research has shown that chromosome abnormalities can be common in eggs and embryos. With advancing age, a woman’s risk of having aneuploid (abnormal number of chromosome) eggs is greatly increased. Clinicians believe this is the main reason why birth rates fall for women in their late thirties and early forties.
When a cell is removed (biopsied) from an embryo, cells are at the un-specialized stage of growth and biopsied embryos will continue to develop into pregnancies and healthy babies.
Testing is performed by extracting and analyzing a single or a few cells from the embryo. We use Micro-array Comparative Genomic Hybridization (MaCGH) and can help select euploid (normal number of chromosome) embryos for transfer to reduce miscarriage rates and hence improving IVF success.
Pre-implantation genetic diagnosis (PGD) is a reproductive technology used with an IVF cycle. It analyses the genetic profile of embryos before their transfer into the womb. PGD offers couples with certain genetic disorders the chance to have an unaffected child. This technique may also be useful in the treatment of those couples whom have had recurrent pregnancy loss or recurrent implantation failures.
Whatsapp Us Button